| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 03/18/2009 | EP1030929B1 Transfection and transfer of non-human male germ cells for generation of transgenic non-human mammals |
| 03/18/2009 | CN101389326A Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives |
| 03/18/2009 | CN101385889A Gynaecologic external traditional Chinese medicine abdominal band |
| 03/18/2009 | CN101385839A Traditional Chinese medicine for treating acute mastitis, hyperphasia of mammary glands |
| 03/18/2009 | CN101385838A Kidney invigoration and sperm production preparation for treating oligospermatism and preparation method thereof |
| 03/18/2009 | CN101385826A Health care medicinal liquor for strenthening yang and preparation method thereof |
| 03/18/2009 | CN101385818A Pregnant aid preparation for treating sterility due to inadequate luteal function and preparation method thereof |
| 03/18/2009 | CN101385806A Traditional Chinese medicine for treating female barrenness |
| 03/18/2009 | CN101385797A Medicine for treating cow hypogalactia after delivery |
| 03/18/2009 | CN100469778C Novel fused imidazole derivative |
| 03/18/2009 | CN100469365C Combination of medication for treating colpitis |
| 03/18/2009 | CN100469363C Therapeutic combinations of fatty acids |
| 03/18/2009 | CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/18/2009 | CN100469357C Tablet for treating difficult menstruation and its preparation |
| 03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use |
| 03/17/2009 | US7504390 Benzoxazepine derivatives and their use as AMPA receptor stimulators |
| 03/17/2009 | US7504096 Methods for in vitro fertilization |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 03/12/2009 | WO2009032249A1 Soluble guanylate cyclase activators |
| 03/12/2009 | WO2009031709A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031708A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031706A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009030725A2 Azaindoles as inhibitors of soluble adenylate cyclase |
| 03/12/2009 | US20090069434 Cystalline form VI of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 03/12/2009 | US20090069371 Isoquinoline compounds |
| 03/12/2009 | US20090069328 Alpha-alkyl substituted n-acyltryptophanols |
| 03/12/2009 | US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity |
| 03/12/2009 | US20090069321 Cyanomethyl substituted n-acyl tryptamines |
| 03/12/2009 | US20090069279 Invert emulsions containing dhea |
| 03/12/2009 | US20090068289 Formulation for menopausal women |
| 03/12/2009 | US20090068284 administering to the uterine cavity a plurality of physiologically inert beads bearing a tissue necrosing amount of silver nitrate as a solid silver ion source; |
| 03/12/2009 | US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt |
| 03/12/2009 | US20090068248 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
| 03/12/2009 | US20090068227 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/12/2009 | US20090068152 Gene transfer for regulating smooth muscle tone |
| 03/12/2009 | CA2698988A1 Composition for separating spermatozoa from a semen sample |
| 03/12/2009 | CA2698747A1 Estrogenic extracts of scuttelaria barbata d. don of the labiatae family and uses thereof |
| 03/11/2009 | EP2033965A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 03/11/2009 | EP2033953A1 Vanilloid receptor modulators |
| 03/11/2009 | EP2033650A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor |
| 03/11/2009 | EP2033634A1 Agent for increasing testosterone level |
| 03/11/2009 | EP2032131A2 Method of treatment |
| 03/11/2009 | EP2032123A1 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP0988374B1 Hydrophilic composition containing protease produced by vibrio proteolyticus |
| 03/11/2009 | CN201205403Y Miscarriage prevention health belt |
| 03/11/2009 | CN101380468A Porcine reproductive and respiratory syndrome bivalence recombinant adenovirus vaccine and preparation method thereof |
| 03/11/2009 | CN101380447A Chitose foaming agent for treating gynecologic disease and preparation method thereof |
| 03/11/2009 | CN101380441A Quality standard of traditional Chinese medicine preparation capable of regulating menstruation, enriching blood, warming uterus, driving cold and relieving pain and inspection method thereof |
| 03/11/2009 | CN101380440A Use of Yunkang oral liquid in preparing medicine for treating kidney-deficiency type sterility |
| 03/11/2009 | CN101380437A Medicine for treating hysteromyoma |
| 03/11/2009 | CN101380434A Yisheng granules and preparation method thereof |
| 03/11/2009 | CN101380410A Medicine for treating hyperactivity of fire due to yin deficiency and preparation method of the formulation thereof |
| 03/11/2009 | CN101380404A Traditional Chinese medicine for treating metrocarcinoma |
| 03/11/2009 | CN101380396A Pudendum powder and preparation method thereof |
| 03/11/2009 | CN101380387A Composition for treating climacteric metancholia and preparation method thereof |
| 03/11/2009 | CN101380381A Traditional Chinese medicine for treating hypogalactia |
| 03/11/2009 | CN101380347A Ainsliaea fragrans Champ total flavone extract and extraction method and use thereof |
| 03/11/2009 | CN101380121A Preparation method of duck steamed with Jing bamboo |
| 03/11/2009 | CN100467450C Anthranilic acid amides and pharmaceutical use thereof |
| 03/11/2009 | CN100467449C Cyclic aminophenyl sulfamate derivative |
| 03/11/2009 | CN100467057C Nerve growth factor external application medicine and its preparing method |
| 03/11/2009 | CN100467051C Chinese medicine preparation for treating breast cystic accrementition |
| 03/11/2009 | CN100467042C Indiscerptible and built in type Chinese traditional preparation for gynecopathy and its preparation process |
| 03/11/2009 | CN100467015C A pharmaceutical composition for treating kidney-qi deficiency syndrome and preparation method thereof |
| 03/10/2009 | US7501525 Derivatives of benzimidazole and their use as medicaments |
| 03/10/2009 | US7501524 Melacocortin receptors; analgesics; antiinflammatory agents; eating disorders; psychological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents |
| 03/10/2009 | US7501441 for treating uterine fibroid disease; [2-(4-hydroxyphenyl)-6-hydroxynaphthalen-1-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methane; therapy for post manupausal women |
| 03/10/2009 | US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/10/2009 | US7501409 A tablet has an acid, with reduced solubility in the neutral and alkaline regions, is used for treating sexual disorders erectile dysfunction |
| 03/10/2009 | CA2415068C Oral compositions comprising antimicrobial agents |
| 03/10/2009 | CA2394602C New modulators of dopamine neurotransmission |
| 03/10/2009 | CA2301057C A method of administering liposomal encapsulated taxane |
| 03/05/2009 | WO2009027003A1 Use of gestagens in combination with (6s)-5-methyltetrahydrofolate for the therapy of endometriosis with simultaneous reduction of therapy side effects and the reduction of the risk of congenital malformations in case of pregnancy |
| 03/05/2009 | US20090062382 External preparation for improving coital function |
| 03/05/2009 | US20090062374 Deuterium-enriched lasofoxifene |
| 03/05/2009 | US20090062308 Methods of using sodium channel blockers |
| 03/05/2009 | US20090062298 Deuterium-enriched sildenafil |
| 03/05/2009 | US20090062226 Method and Compositions for Inhibiting MAGE Protein Interaction With KAP-1 |
| 03/05/2009 | US20090060997 Process for producing a pharmaceutical preparation for therapeutic treatment of endometriosis containing a combination of a gestagen and (6s)-5-methyltetrahydrofolate |
| 03/05/2009 | US20090060982 Methods and devices for the sustained release of multiple drugs |
| 03/05/2009 | US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 03/05/2009 | US20090060931 Pharmaceutical composition for treating or preventing ovarian cancer |
| 03/05/2009 | CA2696030A1 Use of gestagens in combination with (6s)-5-methyltetrahydrofolate for therapy of endometriosis with simultaneous reduction of therapy side effects and reduction of the risk of congenital abnormalities at the onset of a pregnancy |
| 03/04/2009 | EP2029145A2 Pyrrolopyrimidine compounds and their uses |
| 03/04/2009 | EP1578427B1 Use of gnrh agonists to support the luteal phase during infertility treatment |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1463758B1 Mammalian prolactin variants |
| 03/04/2009 | EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 03/04/2009 | EP1401863B1 Somatostatin-dopamine chimeric analogs |
| 03/04/2009 | EP1294876B1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 03/04/2009 | EP1140908B1 Triazole compounds with dopamine-d3-receptor affinity |
| 03/04/2009 | EP0869974B1 Compounds with growth hormone releasing properties |
| 03/04/2009 | CN101376015A Sperm-stopping formulation for treating spermatorrhea and preparation method thereof |